Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001628280-23-030950
Filing Date
2023-08-30
Accepted
2023-08-30 10:19:23
Documents
14
Period of Report
2023-08-30

Document Format Files

Seq Description Document Type Size
1 6-K a230830_6kxmorxvotingright.htm 6-K 11949
2 EX-99.1 exhibit_991.htm EX-99.1 11346
3 GRAPHIC exhibit_991001.jpg GRAPHIC 119814
4 GRAPHIC exhibit_991002.jpg GRAPHIC 125212
5 GRAPHIC exhibit_991003.jpg GRAPHIC 118788
6 GRAPHIC exhibit_991004.jpg GRAPHIC 95166
7 GRAPHIC exhibit_991005.jpg GRAPHIC 89277
8 GRAPHIC exhibit_991006.jpg GRAPHIC 92056
9 GRAPHIC exhibit_991007.jpg GRAPHIC 92082
10 GRAPHIC exhibit_991008.jpg GRAPHIC 91608
11 GRAPHIC exhibit_991009.jpg GRAPHIC 89961
12 GRAPHIC exhibit_991010.jpg GRAPHIC 90611
13 GRAPHIC exhibit_991011.jpg GRAPHIC 100404
14 GRAPHIC exhibit_991012.jpg GRAPHIC 27806
  Complete submission text file 0001628280-23-030950.txt   1585325
Mailing Address SEMMELWEISSTR. 7 PLANEGG 2M 82152
Business Address SEMMELWEISSTR. 7 PLANEGG 2M 82152 49 89 89927-0
MorphoSys AG (Filer) CIK: 0001340243 (see all company filings)

EIN.: 000000000 | State of Incorp.: 2M | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38455 | Film No.: 231223924
SIC: 2834 Pharmaceutical Preparations